New developments in Cryptosporidium research
Top Cited Papers
- 1 May 2015
- journal article
- review article
- Published by Elsevier BV in International Journal for Parasitology
- Vol. 45 (6), 367-373
- https://doi.org/10.1016/j.ijpara.2015.01.009
Abstract
No abstract availableKeywords
Funding Information
- Australian Research Council (LP130100035)
This publication has 92 references indexed in Scilit:
- Drug repurposing and human parasitic protozoan diseasesInternational Journal for Parasitology: Drugs and Drug Resistance, 2014
- Drug Repurposing Screen Reveals FDA-Approved Inhibitors of Human HMG-CoA Reductase and Isoprenoid Synthesis That Block Cryptosporidium parvum GrowthAntimicrobial Agents and Chemotherapy, 2013
- Metabolomic analysis of Cryptosporidium parvum oocysts in water: A proof of concept demonstrationEnvironmental Pollution, 2012
- Waterborne transmission of protozoan parasites: Review of worldwide outbreaks – An update 2004–2010Water Research, 2011
- Human immune responses in cryptosporidiosisFuture Microbiology, 2010
- High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trialBMC Infectious Diseases, 2009
- Morphological characterization ofCryptosporidium parvumlife-cycle stages in anin vitromodel systemParasitology, 2009
- What is Cryptosporidium? Reappraising its biology and phylogenetic affinitiesTrends in Parasitology, 2006
- Estimating The Cost Of New Drug Development: Is It Really $802 Million?Health Affairs, 2006
- Complete Genome Sequence of the Apicomplexan, Cryptosporidium parvumScience, 2004